Adicet bio to present at the 2023 jefferies london healthcare conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced that chen schor, president and chief executive officer, will present at the 2023 jefferies london healthcare conference being held from november 14-16, 2023 in london. details of the event are as follows: date: tuesday, november 14, 2023 time: 5:00 p.m. bst the live audio webcast of.
ACET Ratings Summary
ACET Quant Ranking